Skip to content
Aristo Bio-Tech & Lifescience logo

Aristo Bio-Tech & Lifescience

ARISTO NSE
₹86.00 unchanged 0.00 (0.00%)
Market Cap
₹58.55 Cr

Aristo Bio-Tech & Lifescience (ARISTO) share price was ₹86.00 at the 26 Oct 2026 close; market capitalisation ₹58.55 Cr; sector Chemicals. The share price fell 33.9% over the year to 26 Oct 2026 (adjusted for splits and bonuses). In the Mar 2026 quarter, revenue rose 2.9% year on year to ₹107 Cr and net profit was ₹3 Cr, against under ₹1 Cr a year earlier (compared with Mar 2025). Promoters held 73.42% of Aristo Bio-Tech & Lifescience in Sep 2026, unchanged from Mar 2026.

Close 26 Oct 2026 ₹86.00 −45.30 −34.50% 1Y

Key Fundamentals

SMEFertilizers & AgrochemicalsChemicals
Market Cap
₹58.55 Cr
EBITDA
₹16.50 Cr
Return on Equity
16.29%
Debt to Equity
0.8
Book Value
₹64.79
EPS (TTM)
—
52W High
₹135.00
52W Low
₹74.30

Price-based figures as of 26 Oct 2026, 15:30 IST · TTM

Peer Comparison

Commodities › Chemicals › Pesticides & Agrochemicals

₹540.7522.5845,648 Cr1.321.16%5.38%10.85%53,683 Cr2,323 Cr
₹2,103.8027.3931,918 Cr2.840.72%11.76%14.68%6,914 Cr1,164 Cr
₹333.5528.7016,649 Cr4.500.38%16.00%20.98%3,409 Cr581 Cr
₹3,291.0020.2014,790 Cr4.994.59%23.24%27.93%5,761 Cr733 Cr
₹692.759.986,250 Cr1.992.31%21.71%25.26%5,464 Cr626 Cr
₹884.9514.863,945 Cr2.350.23%21.17%27.37%2,071 Cr268 Cr
₹188.2817.103,661 Cr1.671.58%9.68%12.75%2,631 Cr214 Cr
₹86.00—59 Cr1.330.70%16.29%26.25%——
Median 8 companies₹616.7520.2010,520 Cr2.170.94%16.15%23.12%5,464 Cr626 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100. How it works →

No Tapetide Score has been computed for this stock yet.

Key Insights

Strengths

1
  • Company has delivered good profit growth of 46.1% CAGR over last 5 years

Technical Indicators

Oscillators

Bullish

Bearish
2
Neutral
3
Bullish
4

Overall

Bearish

Bearish
12
Neutral
3
Bullish
4

Moving Averages

Bearish

Bearish
10
Neutral
0
Bullish
0

Growth Rate

Revenue Growth
14.35% lower than 3Y

change over 1 year

Net Income Growth
75.61% higher than 3Y

change over 1 year

Cash Flow Change
-11.68%

change over 1 year

EBITDA Margin Change
48.52%

change over 1 year Operating margin 8% · Mar 2026

Quarterly Results

Particulars Mar 2022Sep 2022Mar 2023Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026
Sales
73
129
89
133
112
214
104
256
107
Expenses
72
124
85
128
109
206
103
249
99
Operating Profit
1
5
4
5
3
8
1
8
8
OPM %
1.2%
3.9%
4.1%
4%
2.9%
3.8%
1.1%
3.1%
8%
Other Income
0
0
0
0
0
0
0
0
0
Interest
1
1
2
1
1
1
1
1
3
Depreciation
1
1
1
1
1
1
1
1
1
PBT
-1
4
1
4
2
6
-1
6
4
Tax %
-35%
28%
13%
28%
27%
25%
-18%
25%
27%
Net Profit
0
3
1
3
1
5
0
4
3
EPS (₹)
-0.48
3.8
1.47
3.78
1.94
6.68
-0.72
6.13
4.42
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales
57
159
271
202
201
167
166
218
245
318
364
Expenses
56
157
263
195
197
163
160
209
236
309
348
Operating Profit
1
3
7
7
5
4
5
9
8
9
16
OPM %
1.6%
1.6%
2.7%
3.4%
2.2%
2.6%
3.3%
4%
3.5%
2.9%
4.4%
Other Income
0
1
1
0
0
0
0
0
0
0
0
Interest
0
1
2
2
3
2
2
3
2
2
4
Depreciation
0
0
0
1
1
1
1
2
2
3
3
PBT
1
3
6
4
1
2
2
5
5
5
10
Tax %
33%
31%
34%
31%
28%
28%
28%
25%
28%
26%
26%
Net Profit
0
2
4
3
1
1
1
4
4
4
7
EPS (₹)
0.8
3.7
7.48
5.67
2.02
2.16
2.14
5.23
5.73
5.96
10.55
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
5%
7%
10%
6%
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
1
1
1
5
5
5
5
7
7
7
7
Reserves
2
4
7
6
7
8
10
23
27
31
37
Borrowings
5
10
20
14
20
22
25
22
21
22
35
Other Liabilities
20
72
60
65
56
46
37
47
73
81
76
Total Liabilities
27
87
89
91
88
81
77
100
127
141
155
Fixed Assets
2
2
8
8
8
12
14
16
22
24
24
CWIP
0
0
0
1
3
0
0
1
0
0
0
Investments
0
0
0
0
0
0
0
0
0
0
0
Other Assets
25
85
81
81
77
69
63
83
106
117
131
Total Assets
27
87
89
91
88
81
77
100
127
141
155
Figures in ₹ Crores

Cash Flow

Particulars Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
—
-4
1
8
1
2
7
-3
8
10
9
Investing
—
0
-5
-2
-2
-2
-3
-4
-7
-5
-3
Financing
—
4
4
-6
1
-1
-3
8
-2
-4
-4
Net Cash Flow
—
0
0
0
0
0
0
1
-1
0
2
Free Cash Flow
—
-4
0
6
-1
0
4
-7
1
5
6
CFO/EBITDA
—
-123
38
138
40
60
134
-17
106
123
71
Figures in ₹ Crores

Ratios

Particulars Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
92
121
65
77
88
72
73
75
86
65
55
Inventory Days
66
67
42
65
47
78
60
57
65
59
70
Days Payable
142
177
85
124
74
93
87
85
112
97
78
Cash Conversion Cycle
16
11
23
18
61
56
46
48
38
26
47
Working Capital Days
3
14
14
15
20
28
25
36
31
22
24
ROCE %
—
31%
34%
24%
14%
11%
12%
16%
13%
13%
20%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Aristo Bio-Tech & Lifescience insights

57 extracted metrics + investor summaries across FY16–FY26.

Shareholding Pattern

Promot.73.42%Others2.32%Public24.26%As ofSep 2026

Documents

Frequently Asked Questions about Aristo Bio-Tech & Lifescience

What does Aristo Bio-Tech & Lifescience Ltd do?
Incorporated in 2005, Aristo Bio-Tech and Lifescience Ltd manufactures and supplies pesticides and agrochemicals[1]
Where is Aristo Bio-Tech & Lifescience Ltd (ARISTO) listed?
Aristo Bio-Tech & Lifescience Ltd trades as ARISTO on the NSE.
Which sector does Aristo Bio-Tech & Lifescience Ltd belong to?
Aristo Bio-Tech & Lifescience Ltd is classified under the Chemicals sector, in the Pesticides & Agrochemicals industry.
What is the market capitalisation of Aristo Bio-Tech & Lifescience Ltd?
Aristo Bio-Tech & Lifescience Ltd has a market capitalisation of ₹58.55 Cr as of 26 Oct 2026, which places it in the Small Cap band.
What is the 52-week high and low of Aristo Bio-Tech & Lifescience Ltd?
Over the last 52 weeks Aristo Bio-Tech & Lifescience Ltd has traded between ₹74.3 and ₹135 as of 26 Oct 2026.
Does Aristo Bio-Tech & Lifescience Ltd pay dividends?
Aristo Bio-Tech & Lifescience Ltd has a dividend yield of 0.70%.
What is the Return on Equity (ROE) of Aristo Bio-Tech & Lifescience Ltd?
Aristo Bio-Tech & Lifescience Ltd reported a return on equity of 16.29%. Its debt-to-equity ratio is 0.80.

Company Information

Incorporated in 2005, Aristo Bio-Tech and Lifescience Ltd manufactures and supplies pesticides and agrochemicals[1]

Listed 2023-01-30
Face Value ₹ 10
Shares Outstanding 68,07,800

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/ARISTO.md for Aristo Bio-Tech & Lifescience Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More